logo

Editorial - Small victory


Just because its dollar denominated products have failed to take off, Eurex US is not letting up in its antitrust allegations against CBoT and CME. Speaking to FO Week earlier this year, Eurex chief executive Rudi Ferscha made it clear that his exchange was very unhappy at what it perceived to be anticompetitive behaviour and would...

The rest of this article is for subscribers only. Would you like to take a free trial?

Free trial

  • News & Analysis access
  • Extensive data searches
  • Access to archive
  • Weekly newsletter

“The banks are investors too. I can’t favour investors with inside information – that’s basically what this is.”

TAM's treasurer voices frustration with Brazil’s new derivatives registration initiative.